Neonatal Septic Shock

Disclaimer: This document provides comprehensive medical information for educational and reference purposes. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be based on the individual patient's condition, available evidence, and the clinician's judgment. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to patient care.

Overview

• Definition: Neonatal septic shock is a life-threatening condition caused by a dysregulated host response to infection, leading to acute circulatory failure, inadequate tissue perfusion, and oxygen delivery. It is characterized by persistent hypotension despite adequate fluid resuscitation, or requiring vasopressor support to maintain blood pressure, and often accompanied by signs of end-organ dysfunction.
• Epidemiology:
  • Incidence: Varies widely globally, estimated at 1-5 per 1,000 live births in developed countries, significantly higher (up to 49 per 1,000 live births) in developing countries, particularly among preterm infants.
  • Mortality: Ranges from 10-50%, with higher rates in preterm infants, those with extreme low birth weight, and those with multi-organ dysfunction or resistant pathogens.
  • Demographics: Preterm infants and those with very low birth weight (<1500g) are at highest risk due to their immature immune systems. Male neonates may have a slightly higher incidence.
• Classification:
  • Early-Onset Sepsis (EOS): Occurs within the first 72 hours of life (some definitions extend to 7 days). Typically acquired vertically from the mother (e.g., during labor and delivery). Common pathogens include Group B Streptococcus (GBS), Escherichia coli (E. coli), and other Gram-negative enteric bacteria.
  • Late-Onset Sepsis (LOS): Occurs after 72 hours of life (or 7 days). Often nosocomial, acquired from the environment or healthcare interventions (e.g., central lines, ventilation). Common pathogens include Coagulase-negative Staphylococci (CoNS), Staphylococcus aureus, Gram-negative enteric bacteria (Klebsiella, Pseudomonas), Candida species.
  • Culture-proven vs. Clinical Sepsis/Shock: Based on positive blood cultures vs. clinical signs and laboratory markers highly suggestive of infection and shock.

Pathophysiology

• Mechanism: Neonates have an immature immune system, characterized by:
  • Impaired Neutrophil Function: Decreased chemotaxis, phagocytosis, and bactericidal activity.
  • Deficient Complement System: Lower levels of complement components (e.g., C3, C5) and impaired opsonization.
  • Immature Adaptive Immunity: Naïve T cells, limited antibody production (especially IgM), and reliance on passively acquired maternal IgG.
  • Dysregulated Inflammatory Response: Upon pathogen exposure (e.g., bacterial endotoxins/LPS or exotoxins), there's a release of pro-inflammatory (TNF-α, IL-1β, IL-6, IL-8) and anti-inflammatory (IL-10) cytokines. In shock, this response becomes dysregulated, leading to widespread endothelial injury, increased capillary permeability, vasodilation, myocardial dysfunction, and metabolic derangements.
  • Cardiovascular Dysfunction: Vasodilation leads to reduced systemic vascular resistance (SVR), while myocardial depression reduces cardiac output (CO). This combination results in hypotension and inadequate tissue perfusion.
  • Metabolic Derangements: Increased anaerobic metabolism due to tissue hypoperfusion leads to lactic acidosis. Hypoglycemia is common due to increased metabolic demand and impaired gluconeogenesis.
• Risk Factors:
  • Maternal Factors (for EOS):
    • Maternal intra-amniotic infection (chorioamnionitis).
    • Prolonged rupture of membranes (PROM) >18-24 hours.
    • Maternal GBS colonization without adequate intrapartum antibiotic prophylaxis.
    • Maternal fever during labor (>38°C or 100.4°F).
    • Preterm labor and delivery.
    • Multiple gestations.
  • Neonatal Factors (for both EOS and LOS, but especially LOS):
    • Prematurity (especially <32 weeks gestation) and very low birth weight (<1500g).
    • Low Apgar scores.
    • Need for resuscitation at birth.
    • Invasive procedures: Endotracheal intubation, mechanical ventilation, central venous catheters, umbilical catheters, urinary catheters.
    • Prolonged hospitalization, especially in the NICU.
    • Total parenteral nutrition (TPN).
    • Skin breakdown, surgical procedures.
    • Congenital anomalies, immunodeficiencies.
• Protective Factors:
  • Antenatal: Maternal GBS prophylaxis, good prenatal care, preventing preterm birth.
  • Perinatal: Aseptic technique during delivery and invasive procedures, early and sustained skin-to-skin contact (Kangaroo Mother Care).
  • Postnatal: Exclusive breastfeeding, strict infection control practices in NICU (hand hygiene, environmental cleaning, judicious use of antibiotics, early removal of invasive lines/catheters).

Clinical Presentation

Neonatal septic shock signs are often subtle, non-specific, and can progress rapidly. Early recognition is crucial.

Signs and Symptoms

• Cardinal Features:
  • Poor Perfusion: Pale/mottled skin, prolonged capillary refill time (>3 seconds), decreased peripheral pulses.
  • Hypotension: Blood pressure below age-specific norms (see values below).
  • Tachycardia: Heart rate >160-180 bpm (can be paradoxically bradycardic in severe cases).
  • Metabolic Acidosis: Lactate >2-4 mmol/L.
  • End-Organ Dysfunction: Signs related to specific organ system failure.
• Early Signs:
  • Non-specific Behavioral Changes: Lethargy, irritability, poor feeding, weak suck.
  • Thermoregulation Instability: Hypothermia (most common), or fever (less common in preterm, but can occur).
  • Respiratory Distress: Tachypnea, grunting, flaring, retractions, apnea, cyanosis.
  • Cardiovascular: Mild tachycardia, poor skin color, cool extremities.
  • Gastrointestinal: Abdominal distension, vomiting, poor feeding, increased gastric residuals.
• Advanced Signs:
  • Severe Cardiovascular Collapse: Profound hypotension, severe bradycardia, extremely prolonged capillary refill time (>5 seconds), absent peripheral pulses, weak central pulses.
  • Respiratory Failure: Severe apnea, gasping, requiring mechanical ventilation.
  • Neurological: Seizures, decreased level of consciousness, absent reflexes, bulging fontanelle.
  • Renal: Oliguria (<1 mL/kg/hour) or anuria.
  • Hematologic: Petechiae, purpura, bleeding (signs of DIC).
  • Metabolic: Persistent lactic acidosis despite fluid resuscitation, severe hypoglycemia or hyperglycemia.
• Atypical Presentations:
  • Bradycardia instead of tachycardia, especially in very preterm infants.
  • Persistent hyperglycemia without clear cause.
  • Unexplained abdominal distension or necrotizing enterocolitis-like symptoms without frank NEC.
  • "Well-appearing" until sudden rapid deterioration.

Physical Examination

• Inspection:
  • Skin: Pallor, mottling (lacy appearance), cyanosis, petechiae, purpura, jaundice. Assess for skin lesions, pustules, omphalitis, cellulitis.
  • General Appearance: Lethargy, decreased activity, floppy tone, weak cry, poor suck.
  • Breathing: Respiratory rate (tachypnea >60 bpm), signs of distress (retractions, grunting, nasal flaring), periodic breathing, apnea.
  • Abdomen: Distension, erythema, tenderness.
  • Neurological: Level of consciousness, responsiveness, abnormal movements, seizures.
• Palpation:
  • Temperature: Core (rectal) vs. peripheral (extremities) temperature discrepancy (cool extremities despite normal core).
  • Pulses: Evaluate peripheral pulses (femoral, brachial, radial, dorsalis pedis) for rate, rhythm, and quality (weak, thready, bounding).
  • Capillary Refill Time (CRT): Apply pressure to the sternum or sole of foot for 5 seconds; normal is <2 seconds, >3 seconds indicates poor perfusion.
  • Fontanelles: Assess for bulging or sunken fontanelle.
  • Abdomen: Tenderness, masses.
• Special Tests:
  • Blood Pressure Measurement: Crucial for defining shock. Use an appropriately sized cuff (bladder width 40% of arm circumference).
    • Mean Arterial Pressure (MAP) thresholds for hypotension:
      • Term neonate: <40-50 mmHg
      • Preterm neonate: <30-40 mmHg (or often less than gestational age in weeks)
    • Note: Hypotension in neonates is a late sign of shock; early signs of poor perfusion can be present with normal BP.

Diagnostic Approach

History Taking

• Key Questions:
  • Maternal History: GBS status and prophylaxis, intrapartum fever, prolonged rupture of membranes, chorioamnionitis, maternal infections (e.g., HSV, HIV).
  • Perinatal History: Gestational age, birth weight, mode of delivery, Apgar scores, need for resuscitation, meconium-stained amniotic fluid.
  • Postnatal History: Onset and progression of symptoms (e.g., feeding changes, respiratory distress, lethargy, fever/hypothermia). Exposure to sick contacts.
  • Hospitalization Course (for LOS): Duration of hospitalization, central lines, mechanical ventilation, surgical procedures, antibiotic exposure, TPN use.
• Red Flags:
  • Rapid deterioration from stable to critical condition.
  • Persistent hypotension despite fluid boluses.
  • New onset of seizures or decreased level of consciousness.
  • Sudden onset of abdominal distension with feeding intolerance.
  • Worsening respiratory distress requiring increased support.
  • Unexplained metabolic acidosis or profound lactic acidosis.

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC) with Differential:
    • Neutropenia (absolute neutrophil count <1,500/mm³ for term; <1,000/mm³ for preterm) is highly suggestive.
    • Neutrophilia (>20,000-25,000/mm³) also concerning.
    • Immature-to-total neutrophil ratio (I:T ratio) >0.20-0.25 is a strong indicator of infection.
    • Thrombocytopenia (<100,000/mm³) common in severe sepsis/shock.
  • C-Reactive Protein (CRP):
    • Elevated CRP (>10 mg/L or >1.0 mg/dL) suggests inflammation/infection. Serial measurements are useful as it may be normal early in infection but rise by 12-24 hours.
  • Blood Culture: ESSENTIAL for definitive diagnosis. Obtain at least 1 mL from a peripheral vein (or central line if already present). Prioritize before antibiotics if possible, but do not delay antibiotics significantly.
  • Blood Gas Analysis: Assess pH, PCO2, PO2, bicarbonate. Look for metabolic acidosis.
  • Lactate: Elevated lactate (>2 mmol/L, with levels >4 mmol/L indicating severe shock) reflects tissue hypoperfusion and anaerobic metabolism. Serial measurements guide resuscitation.
  • Glucose: Hypoglycemia (<40-50 mg/dL) or hyperglycemia (>125-150 mg/dL) are common.
  • Electrolytes, Renal Function Tests (BUN, Creatinine): Assess for electrolyte imbalances and renal dysfunction.
• Confirmatory:
  • Positive Blood Culture: Gold standard for diagnosing bacteremia/fungemia.
  • Cerebrospinal Fluid (CSF) Analysis: Performed if suspicion for meningitis (e.g., positive blood culture, neurological symptoms, septic shock without clear focus). Gram stain, cell count, protein, glucose, and culture.
  • Urine Culture: Via catheterization or suprapubic aspirate (bag urine not reliable). Consider in LOS or if urinary symptoms.
  • Procalcitonin (PCT):
    • Rises earlier and more specifically than CRP, particularly in bacterial infections. Levels >2 ng/mL are often considered highly suggestive of bacterial sepsis. Can be used for antibiotic stewardship.
• Monitoring:
  • Serial CBC, CRP, PCT, blood gas, lactate to assess response to therapy.
  • Serial electrolytes, renal and liver function tests to monitor organ dysfunction.
  • Fluid balance (intake/output).
  • Vital signs (HR, RR, BP, SpO2, temp) continuously.

Imaging

• Recommended:
  • Chest X-ray (CXR): To assess for pneumonia, pulmonary edema (common in fluid overload or ARDS), or other respiratory pathology.
  • Abdominal X-ray (AXR): To rule out necrotizing enterocolitis (NEC) if abdominal symptoms are present (e.g., bowel distension, tenderness, bloody stools). Look for pneumatosis intestinalis.
• Advanced:
  • Cranial Ultrasound: Indicated if there are neurological signs (seizures, bulging fontanelle, altered consciousness) to rule out intracranial hemorrhage or ventriculitis.
  • Echocardiogram: Consider if there is persistent hypotension despite fluid and vasopressor therapy, significant myocardial dysfunction suspected, or to assess for pericardial effusion or congenital heart disease.

Management

Neonatal septic shock is a medical emergency requiring immediate, aggressive, and coordinated intervention. The goal is to restore tissue perfusion and oxygen delivery while treating the underlying infection.

Acute Management

• Immediate (First Hour Interventions - "Golden Hour"):
  1. Recognition: Promptly identify signs of shock.
  2. ABCs (Airway, Breathing, Circulation):
     • Airway: Ensure patent airway. Intubate if respiratory failure or impending arrest.
     • Breathing: Provide ventilatory support (Nasal CPAP, mechanical ventilation) to maintain adequate oxygenation (SpO2 90-95%) and ventilation (PCO2 45-55 mmHg).
     • Circulation: Establish vascular access (umbilical venous catheter, peripheral IV).
  3. Fluid Resuscitation: Administer rapid intravenous fluid boluses.
     • Initial Bolus: 10-20 mL/kg of isotonic crystalloid (0.9% Normal Saline or Ringer's Lactate) over 5-10 minutes.
     • Repeat Boluses: Can repeat up to 2-3 boluses (total 30-60 mL/kg) within the first hour if no improvement in perfusion and no signs of fluid overload (e.g., crackles, worsening respiratory distress, hepatomegaly). Caution in preterm infants: They are more susceptible to fluid overload and IVH.
  4. Empiric Antibiotics: Administer broad-spectrum intravenous antibiotics immediately after blood cultures are drawn, without waiting for results.
     • Early-Onset Sepsis (EOS): Ampicillin + Gentamicin (first-line). If suspicion for meningitis or G-negative resistant organisms (e.g., from severe chorioamnionitis), consider Ampicillin + Cefotaxime.
     • Late-Onset Sepsis (LOS) / Hospital-acquired: Vancomycin + Cefotaxime or Gentamicin (depending on local epidemiology and suspected pathogens). For suspicion of Pseudomonas, consider Piperacillin-Tazobactam or Meropenem.
     • Dosages (Examples, adjust for gestational/postnatal age):
       • Ampicillin: 50-100 mg/kg/dose IV every 8-12 hours.
       • Gentamicin: 2.5-5 mg/kg/dose IV every 24-48 hours (adjust for renal function, monitor levels).
       • Cefotaxime: 50 mg/kg/dose IV every 8-12 hours.
       • Vancomycin: 10-15 mg/kg/dose IV every 8-12 hours (monitor levels).
  5. Vasopressor/Inotrope Support: If hypotension persists despite 40-60 mL/kg fluid resuscitation, initiate vasoactive medications.
     • Dopamine: Start at 5-10 mcg/kg/min IV infusion, titrate up to 20 mcg/kg/min.
     • Dobutamine: If myocardial dysfunction suspected (low CO, normal SVR), start at 5-10 mcg/kg/min IV infusion.
     • Norepinephrine (Levophed): For "cold shock" (high SVR) or refractory "warm shock" (low SVR). Start at 0.05-0.1 mcg/kg/min, titrate up to 0.5-2 mcg/kg/min. Consider after initial dopamine/dobutamine or if profound vasodilatory shock.
     • Epinephrine: For profound shock or cardiac arrest. Start at 0.05-0.1 mcg/kg/min, titrate up to 0.5 mcg/kg/min.
• Stabilization (Ongoing Management):
  • Monitor: Continuous monitoring of vital signs, perfusion (CRT, urine output, lactate), blood pressure, central venous pressure (if central line present), and glucose.
  • Metabolic Support:
    • Glucose: Maintain euglycemia (70-100 mg/dL). Dextrose infusion rate often needs to be increased (e.g., D10W at 8-12 mg/kg/min).
    • Calcium: Correct hypocalcemia (ionized calcium <1.0-1.1 mmol/L) as it impairs myocardial contractility. Administer calcium gluconate 100 mg/kg IV over 10-15 minutes.
    • Acidosis: Correct severe metabolic acidosis (pH <7.2) with sodium bicarbonate only if ventilation is adequate and not solely due to hypovolemia.
  • Adrenal Insufficiency: Consider empiric hydrocortisone (e.g., 1-2 mg/kg/day divided q6h or 0.5 mg/kg IV bolus followed by 0.5 mg/kg/day continuous infusion) in refractory shock unresponsive to fluids and vasopressors, or if adrenal hemorrhage is suspected.
  • Transfusion: Consider packed red blood cells (PRBCs) if hemoglobin is low (<7-8 g/dL) and contributing to oxygen delivery issues, or if active bleeding.
  • Central Venous Access: Secure central venous access (e.g., umbilical venous catheter, peripherally inserted central catheter - PICC) for continuous infusions and pressure monitoring.

Chronic Management

• Pharmacological:
  • Targeted Antibiotics: Once culture results and sensitivities are available, narrow the antibiotic regimen to the most appropriate narrow-spectrum agent. Continue for 7-14 days (or longer for specific infections like meningitis, osteomyelitis, or fungal infections).
  • Antifungal Agents: If fungal infection is suspected or confirmed (e.g., Candida), initiate amphotericin B (0.5-1 mg/kg/day) or fluconazole (6-12 mg/kg/dose, dosing frequency varies with age/weight).
  • Ongoing Vasopressor/Inotrope Weaning: Gradually wean vasoactive medications as perfusion and blood pressure normalize.
• Non-pharmacological:
  • Nutritional Support: Aggressive nutritional support (parenteral and then enteral) is crucial for recovery. Initiate trophic feeds as soon as hemodynamically stable.
  • Infection Control: Strict adherence to hand hygiene, central line bundles, ventilator bundles, and environmental cleaning to prevent secondary infections.
  • Supportive Care: Temperature regulation, pain management, skin care.
• Monitoring:
  • Long-term follow-up: Due to risk of neurodevelopmental impairment.
  • Organ-specific monitoring: Renal function, liver function, cardiac function, lung function based on complications.

Treatment Algorithms

• First-Line (Initial Response):
  1. Recognize Shock: Poor perfusion, hypotension, signs of organ dysfunction.
  2. Establish Vascular Access.
  3. Fluid Resuscitation: 10-20 mL/kg bolus crystalloid (repeat up to 3 times, 30-60 mL/kg total) over 5-10 minutes each.
  4. Empiric Broad-Spectrum Antibiotics: Based on EOS/LOS protocol (e.g., Ampicillin + Gentamicin/Cefotaxime; Vancomycin + Cefotaxime/Gentamicin).
  5. Correct Metabolic Derangements: Glucose, Calcium, Acidosis (if severe).
• Second-Line (Refractory to Fluids):
  1. Initiate Inotropes/Vasopressors:
     • First choice: Dopamine (5-20 mcg/kg/min).
     • If signs of myocardial dysfunction: Dobutamine (5-10 mcg/kg/min) in addition to or instead of dopamine.
     • If signs of vasodilatory shock or refractory to dopamine: Norepinephrine (0.05-0.5 mcg/kg/min).
  2. Consider Stress Dose Hydrocortisone: If adrenal insufficiency suspected or unresponsive to fluids/vasopressors.
  3. Blood Transfusion: If severe anemia contributing to oxygen deficit.
  4. Echocardiography: To assess cardiac function and guide inotrope choice.
• Refractory Cases (Persistent Shock despite above):
  1. Review Diagnosis: Rule out other causes of shock (e.g., congenital heart disease, severe hemorrhage, adrenal crisis).
  2. Higher Doses/Combinations of Vasoactives: Consider combinations of dopamine, dobutamine, norepinephrine, epinephrine.
  3. Consider ECMO (Extracorporeal Membrane Oxygenation): If severe cardiopulmonary failure and unable to maintain perfusion despite maximal conventional support, consider transfer to an ECMO center if criteria are met.
  4. Vasopressin: Can be considered (0.0003-0.002 units/kg/min) as an adjunct in refractory vasodilatory shock.

Complications

• Common:
  • Acute Kidney Injury (AKI)
  • Acute Respiratory Distress Syndrome (ARDS)
  • Disseminated Intravascular Coagulation (DIC)
  • Hypoglycemia/Hyperglycemia
  • Electrolyte disturbances (e.g., hyponatremia, hyperkalemia)
  • Hypotension-induced brain injury (e.g., periventricular leukomalacia, intraventricular hemorrhage in preterm infants)
  • Necrotizing Enterocolitis (NEC)
• Serious:
  • Multi-Organ Dysfunction Syndrome (MODS)
  • Brain damage (hypoxic-ischemic encephalopathy, seizures)
  • Septic cardiomyopathy/Myocardial dysfunction
  • Renal failure requiring dialysis
  • Pulmonary hemorrhage
  • Death
• Long-term:
  • Neurodevelopmental impairment (cerebral palsy, developmental delay, learning disabilities, hearing/visual impairment)
  • Chronic lung disease/Bronchopulmonary Dysplasia (BPD)
  • Renal insufficiency
  • Growth failure
  • Recurrent infections

Prognosis

• Factors:
  • Gestational Age and Birth Weight: Preterm and very low birth weight infants have poorer prognosis.
  • Severity of Shock: Presence of multi-organ dysfunction, requirement for high-dose vasopressors, and persistent lactic acidosis predict worse outcomes.
  • Pathogen: Virulent organisms (e.g., Pseudomonas, resistant Gram-negatives, Candida) are associated with higher mortality.
  • Timeliness of Treatment: Early recognition and aggressive management significantly improve survival.
  • Presence of Meningitis: Worsens neurological outcome.
• Survival: Varies from 50-90% depending on the factors above, with higher mortality in extremely premature infants and those with severe MODS.
• Quality of Life: Significant proportion of survivors, especially those with severe shock, experience long-term neurodevelopmental sequelae, impacting their quality of life and requiring extensive supportive services.

Prevention

• Primary (Preventing Initial Occurrence):
  • Antenatal: Universal GBS screening for pregnant women at 35-37 weeks gestation and intrapartum antibiotic prophylaxis (IAP) for positive GBS carriers or those with risk factors (e.g., PROM, preterm labor).
  • Perinatal: Aseptic technique during labor and delivery, judicious use of invasive procedures.
  • Postnatal:
    • Hand Hygiene: Strict adherence to hand hygiene for all healthcare providers and visitors.
    • Infection Control Bundles: Implementation of central line-associated bloodstream infection (CLABSI) prevention bundles, ventilator-associated pneumonia (VAP) prevention bundles.
    • Judicious Antibiotic Use: Avoid unnecessary antibiotic exposure to reduce antimicrobial resistance and dysbiosis.
    • Early Enteral Feeding and Breastfeeding: Promote gut health and provide immune factors.
    • Environmental Control: Regular cleaning and disinfection of patient care areas and equipment.
    • Vaccinations: Maternal vaccinations (e.g., flu, Tdap) provide passive immunity. Neonatal vaccinations as per schedule.
• Secondary (Early Detection and Intervention):
  • High Index of Suspicion: For any neonate with non-specific signs of illness, especially those with risk factors.
  • Prompt Evaluation: Rapid clinical assessment and initiation of diagnostic workup (blood cultures, labs) if sepsis is suspected.
  • Early Fluid Resuscitation and Antibiotics: As detailed in acute management.
• Tertiary (Preventing Complications):
  • Aggressive Supportive Care: To minimize organ damage (e.g., careful fluid balance, ventilator management, glucose control).
  • Neurodevelopmental Follow-up: Implement early intervention programs for infants who suffered severe sepsis/shock to mitigate long-term neurological sequelae.
  • Rehabilitation Services: Physical, occupational, and speech therapy as needed.

Special Populations

• Preterm Neonates:
  • Increased Risk: Higher incidence of sepsis and septic shock due to extreme immune immaturity, increased invasive procedures, and prolonged hospitalization.
  • Subtle Presentation: Signs are often even more vague (e.g., isolated apnea, bradycardia, temperature instability).
  • Fluid Management: More susceptible to fluid overload, pulmonary edema, and intraventricular hemorrhage (IVH). Boluses should be given more cautiously (e.g., 5-10 mL/kg over 10-15 min) with close monitoring for fluid responsiveness and signs of overload.
  • Blood Pressure: Lower normal BP values.
  • Prognosis: Worse outcomes regarding mortality and neurodevelopmental impairment.

Note: The remaining special populations (Geriatric, Pregnancy, Comorbidities) are not directly applicable to "Neonatal Septic Shock" as the topic is restricted to neonates. Neonates themselves are a special population requiring specific considerations relative to older children/adults.

Clinical Pearls

• Diagnostic:
  • "Sick-looking" baby: Any neonate who "doesn't look right" or has vague symptoms (lethargy, poor feeding, color changes) should raise a high suspicion for sepsis/shock, especially if risk factors are present.
  • Non-specific signs: Remember that fever is rare in preterm neonates; hypothermia or temperature instability is more common. Apnea/bradycardia can be the sole early sign.
  • Lactate is key: A rising lactate level is a critical indicator of worsening shock and poor perfusion, even if BP appears stable.
  • CRP and PCT kinetics: Don't rely on a single normal CRP/PCT level early in the course; follow serial measurements.
• Treatment:
  • Time is muscle/brain: Rapid recognition and intervention within the "golden hour" are paramount to improve outcomes.
  • Fluid management is tricky: While fluids are critical initially, avoid aggressive fluid loading, especially in preterm infants, due to risk of pulmonary edema and IVH. Use fluid responsiveness as a guide.
  • Early vasopressors: Don't hesitate to start vasopressors if fluids alone don't restore perfusion and BP.
  • Glucose management: Close monitoring of blood glucose is essential to prevent both hypo- and hyperglycemia.
  • Central line hygiene: Strict adherence to CLABSI prevention bundles is critical for NICU patients to prevent LOS.
• Pitfalls:
  • Underestimation: Missing subtle signs or attributing symptoms to less serious conditions.
  • Delayed antibiotics: Waiting for blood culture results or other labs before starting empiric antibiotics.
  • Inadequate fluid resuscitation: Not giving enough fluids initially OR giving too much fluid leading to overload.
  • Delayed vasopressor initiation: Waiting too long when fluids are ineffective.
  • Over-reliance on blood pressure: Blood pressure may be maintained by compensatory mechanisms until shock is severe. Focus on perfusion parameters (CRT, lactate, urine output).

Recent Updates

• Guidelines: The Pediatric Advanced Life Support (PALS) guidelines and the Surviving Sepsis Campaign (SSC) guidelines for pediatric and neonatal sepsis are regularly updated. The 2020 PALS and 2020 SCCM/ESICM Guidelines for Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children (which include neonates) emphasize:
  • Rapid administration of IV fluids (10-20 mL/kg boluses) but with caution, especially in resource-limited settings or suspected cardiac dysfunction.
  • Earlier initiation of vasoactive agents if fluid resuscitation is not rapidly effective.
  • Emphasis on balancing fluid administration with risk of fluid overload.
  • Role of point-of-care ultrasound (POCUS) in assessing fluid responsiveness and cardiac function.
  • De-escalation of antibiotics based on cultures and procalcitonin.
• Evidence:
  • Fluid Resuscitation Debate: Ongoing research debates the optimal volume and rate of fluid resuscitation, particularly in resource-limited settings where fluid overload is a greater concern without ICU support. Current recommendations still lean towards initial boluses but with close monitoring.
  • Biomarkers: Procalcitonin is increasingly used to guide antibiotic duration and de-escalation in both EOS and LOS, although its predictive value for onset of sepsis still has limitations.
  • Vasopressors: Growing evidence supports the use of norepinephrine in neonatal septic shock, even as a first-line vasopressor in specific scenarios (e.g., warm shock), alongside dopamine and dobutamine.
• Controversies:
  • Steroid Use: While stress-dose hydrocortisone is recommended for fluid- and vasopressor-refractory shock, the exact indications, dose, and duration remain subjects of ongoing debate and research in neonates.
  • Optimal Fluid Strategy: The amount of fluid bolus, the number of repeated boluses, and when to transition to vasopressors vs. further fluids remains a challenge, balancing resuscitation with the risk of fluid overload.
  • Role of IVIG: Routine use of intravenous immunoglobulin (IVIG) for neonatal sepsis is not recommended due to lack of consistent evidence of benefit, but it is sometimes considered in specific clinical scenarios without strong evidence.

Key References

• Guidelines:
  • Weiss SL, et al. Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Intensive Care Med. 2020;46(Suppl 1):1-10.
  • PALS (Pediatric Advanced Life Support) Guidelines. American Heart Association/American Academy of Pediatrics (latest edition).
  • Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006-15. (While older, still foundational for EOS).
• Studies:
  • Rivers EP, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-77. (Landmark adult study influencing pediatric/neonatal sepsis management).
  • PRoMPT BOLUS trial (Fluid bolus therapy in critically ill children in Africa). N Engl J Med. 2015;372(6):531-40. (Highlights risks of aggressive fluid boluses in specific settings).
• Reviews:
  • Shane AL, et al. Neonatal Sepsis. N Engl J Med. 2017;377(1):50-60.
  • Klinnert VD, et al. Neonatal Sepsis: A Review for the Clinician. Clin Perinatol. 2015;42(1):31-50.

Disclaimer: This document provides comprehensive medical information for educational and reference purposes. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be based on the individual patient's condition, available evidence, and the clinician's judgment. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to patient care.